Get All Access for $5/mo

Kodak Secures $765 Million Government Loan to Produce Drugs It remains unclear exactly what potions Kodak Pharmaceuticals will be brewing.

By Stephanie Mlot

This story originally appeared on PCMag

Pixabay via PC Mag

There is a lot more demand these days for medication than photographic film, so Eastman Kodak has decided to get into drugs, and the Trump administration is supporting its initiative with a $765 million loan.

The new business unit, according to Kodak, will produce "critical pharmaceutical components" to help rebuild the national stockpile depleted by COVID-19. Once fully operational, Kodak Pharmaceuticals will develop up to one quarter of the active ingredients used in non-biologic, non-antibacterial, generic drugs while supporting more than 1,500 jobs.

"By leveraging our vast infrastructure, deep expertise in chemicals manufacturing, and heritage of innovation and quality, Kodak will play a critical role in the return of a reliable American pharmaceutical supply chain," Executive Chairman Jim Continenza said. Existing manufacturing plants in Rochester, N.Y., and St. Paul, Minn., will be retooled for the new division.

Since the company's founding by George Eastman in 1888, Kodak has been supplying consumers with cameras, film, chemicals, and paper. The firm is no stranger to complicated compounds: In 1920, Tennessee Eastman was founded to manufacture chemicals needed for film photography products; more than 70 years later, Eastman Chemical was spun off as a separate corporation, which became a Fortune 500 company.

"We are pleased to support Kodak in this bold new venture," Adam Boehler, CEO of capital provider US International Development Finance Corporation, said in a statement. "Our collaboration with this iconic American company will promote health and safety at home and around the world."

It remains unclear exactly what potions Kodak Pharmaceuticals will be brewing. The Wall Street Journal hinted at antimalarial drug hydroxychloroquine, which Donald Trump has touted in the treatment of coronavirus; DFC revealed only that the components are "essential," but have lapsed into chronic national shortage, as defined by the Food and Drug Administration.

Kodak isn't the only photography firm fighting coronavirus: As the BBC pointed out, Japan's Fujifilm is working on a potential COVID-19 vaccine, and hopes to start human trials soon.

Stephanie Mlot

Reporter at PCMag

Stephanie began as a PCMag reporter in May 2012. She moved to New York City from Frederick, Md., where she worked for four years as a multimedia reporter at the second-largest daily newspaper in Maryland. She interned at Baltimore magazine and graduated from Indiana University of Pennsylvania (in the town of Indiana, in the state of Pennsylvania) with a degree in journalism and mass communications.

Want to be an Entrepreneur Leadership Network contributor? Apply now to join.

Editor's Pick

Business News

How to Be a Billionaire By 25, According to a College Dropout Turned CEO Worth $1.6 Billion

Austin Russell became the world's youngest self-made billionaire in 2020 at age 25.


Taylor Swift Has a Lucky Number. And She's Not the Only High Performer Who Leans Into Superstitions to Boost Confidence.

Even megastars like Swift need a little extra something to get them in the right mindset when it is game time.


SEO Trends You Need to Be Aware of Right Now, According to a Seasoned Pro

Navigate the future of search engine optimization to elevate your online presence and drive meaningful engagement.

Business Ideas

63 Small Business Ideas to Start in 2024

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2024.


These 3 Big Tech Companies Offer 6-Figure Salaries and Easy Interviews — Especially If You Follow This Expert's Advice

There are far more candidates than positions, so being strategic on the job hunt is key.